Suitability of Capillary Blood Glucose Analysis in Patients Receiving Vasopressors
Myra F. Ellis, RN, MSN, Kesi Benjamin, RN, Morgan Cornell, RN, Kelsey Decker, RN, Debra Farrell, RN, Lynn McGugan, RN, DNP, Gloria P. Porter, RN, Helen Shearin, RN, Yanfang Zhao, MS, and Bradi B.Granger, RN, PhD
Suitability of Capillary Blood Glucose Analysis in Patients Receiving Vasopressors: Read Article
Get CNE

Learning Objectives

At the completion of this program, you will be able to:
  • Identify the factors that can affect the accuracy of blood sugar testing.
  • Discuss what blood glucose testing method is acceptable for patients with less than 2, or more than 2 vasopressors.
  • Describe the potential consequences of using an inaccurate blood glucose testing method.

Continuing Education Information

CE ID: A132253
Total Contact Hours: 1.00
Pharma Hours: 0.0
Synergy Cat: A
Test Expires: 9/1/2016

Description

Glycemic control in critically ill patients decreases infection and mortality. Patients receiving vasopressors have altered peripheral perfusion, which may affect accuracy of capillary blood glucose values measured with point-of-care devices.

Publication/Sponsor Information


American Journal of Critical Care is an official publication of the American Association of Critical-Care Nurses (AACN), and copyright belongs to AACN. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or by any information storage retrieval system without permission of AACN. For all permission requests, please contact the Copyright Clearance Center, Customer Service, 222 Rosewood Drive, Danvers, MA 01923. (978) 750-8400. The statements and opinions contained herein are solely those of individual contributors and not of the editors, AACN, or The InnoVision Group. The editors, AACN, and The InnoVision Group assume that articles emanating from a particular institution are submitted with the approval of the requisite authority, including all matters pertaining to human studies and patient privacy requirements.

You have currently started taking the test for . To continue your test in progress, select Return to Test. To abandon this test select Cancel.

Your Feedback